H. Lundbeck news

HLUN.A · Nasdaq Copenhagen · DKK

kr 43.20+1.41%+kr 0.60

Close · October 6, 2026

Latest news

Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports (opens in a new tab)
Investing.com · Sep 29, 2026
Can H. Lundbeck (CPSE:HLUN B) Look Cheap On Japan Eptinezumab Approval? (opens in a new tab)
Simply Wall St. · Sep 28, 2026
H. Lundbeck AS (HLUBF) (Q2 2026) Earnings Call Highlights: Strategic Brands Drive 16% Revenue ... (opens in a new tab)
GuruFocus.com · Aug 19, 2026
H. Lundbeck AS (HLUBF) Full Year 2025 Earnings Call Highlights: Record Growth and Strategic Advances (opens in a new tab)
GuruFocus.com · Feb 4, 2026
Avadel (AVDL) Gets 26% Boost on Takeover Bid (opens in a new tab)
Insider Monkey · Nov 16, 2025
Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War (opens in a new tab)
Insider Monkey · Nov 15, 2025
H. Lundbeck AS (HLUBF) Q3 2025 Earnings Call Highlights: Robust Growth and Strategic Advancements (opens in a new tab)
GuruFocus.com · Nov 12, 2025